Table: Rohto -Q1 group results

Rohto Pharmaceutical

06/08/2025 07:32

Aug 6 (Reuters)- 
             Rohto Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   3 months ended      3 months ended       Year to 
                  Jun 30, 2025        Jun 30, 2024     Mar 31, 2026 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales               81.96               68.36           334.50    
                   (+19.9 pct)         (+11.7 pct)      (+8.4 pct)  
  Operating           11.70               11.79            39.00    
                   (-0.8 pct)          (+4.4 pct)       (+2.0 pct)  
  Recurring           16.13               12.27            43.00    
                   (+31.4 pct)         (+0.2 pct)       (+8.2 pct)  
  Net                 11.77                8.48            31.50    
                   (+38.7 pct)         (-6.7 pct)       (+2.1 pct)  
  EPS               52.09 yen           37.18 yen       139.40 yen  
  EPS Diluted       51.39 yen           37.08 yen                   
  Ann Div                               36.00 yen        42.00 yen  
  -Q2 div                               16.00 yen        21.00 yen  
  -Q4 div                               20.00 yen        21.00 yen  
  
  NOTE - Rohto Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4527.T